HOME >> MEDICINE >> NEWS
Preparing for European market launch

Ventracor Limited (ASX: VCR) today announced the first patient has been implanted with the VentrAssist in a new study designed to build on clinical momentum from the CE Mark Trial and prepare for European market launch.

The BRACE study (Baseline Results And Cost Effectiveness) will add to the body of evidence for the performance of the VentrAssist left ventricular assist device (LVAD) in up to 10 new centres in Europe. The new centres are in addition to the current Australian, NZ and European sites.

The BRACE study is a key component of Ventracor's commercialisation strategy to rapidly grow revenues after the anticipated CE Mark approval in early 2007.

The cost effectiveness results of the BRACE study will also be used to help obtain or increase reimbursement in key European markets.

After approval by the Regional Hospital Ethics Committee in Oslo, Norway, the first patient in the BRACE study, a 16 year-old girl was implanted last week.

Principal Investigator Dr Arnt Fiane at Rikshopitalet - Radiumhospitalet Medical Centre said: "We are excited about participating in the BRACE study for this potentially world-leading life-saving technology." Dr. Fiane added the patient was making a satisfactory recovery.

Ventracor Limited Chief Operating Officer Peter Crosby said: "We are very conscious that regulatory approval does not immediately equate to market acceptance.

"The BRACE study builds on the CE Mark Trial to expand clinical knowledge and understanding of the VentrAssist."

"By the time the VentrAssist receives CE mark approval later this year, we expect to have many more centres implanting the VentrAssist under the BRACE protocol and we can rapidly move to grow revenues from this established customer base.

"There have now been more VentrAssist third generation (3G) centrifugal LVADs implanted than all third generation centrifugal pumps from all our competitors combined," Mr Crosby said.


'"/>

Contact: Andrew Geddes
61-29-406-3086
Research Australia
19-Jun-2006


Page: 1

Related medicine news :

1. Preparing for an influenza pandemic: A triage protocol in the face of limited resources
2. Rutgers College of Nursing to host Preparing for Natural Disasters Forum November 3
3. Preparing our medical frontline for the future
4. Look to the future: Preparing for baby boomer dementia epidemic
5. European heat waves double in length since 1880
6. European Space Agencys Envisat captures breath of volcano
7. Polish journalist scoops first prize in prestigious European award
8. UK and other European countries should introduce universal childhood hepatitis B vaccination
9. Elsevier partners with European Federation of Organizations for Medical Physics
10. Asia-European collaboration addresses water management in Indonesia
11. Leading European experts in magnetic resonance for animals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... October 17, 2019 , ... Dr. Parsa Mohebi, the ... Angeles and Beverly Hills, is reminding patients interested in undergoing a hair transplant that ... , According to Dr. Mohebi, “The holidays are a time for friends and family ...
(Date:10/15/2019)... Va. (PRWEB) , ... October 15, 2019 , ... ... Complying with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, October ... recent Instructions for Use (IFU) guidance have on new drug applications and biologics ...
(Date:10/11/2019)... ... October 11, 2019 , ... Inland Detox, Inc. has just moved ... location has incredible views of the Temecula Valley and it’s the perfect place for ... facility offers both private rooms as well as double occupancy rooms, a 2nd home ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Annual Conference, Nutrition 21 was excited to hear the significant results of an ... blood flow impact of Nitrosigine®. The clinical study poster entitled “The Acute Effects ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon ... Jose, CA experience relief from this common and treatable condition. Dr. HagShenas’ goal is ... adults from living with uncomfortable symptoms, including tender and bleeding gums, and to prevent ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... ... ... Hospital M&A activity held steady with 21 transactions in both the second and ... quarter was down 20% compared with the same period in 2018, when 25 deals ... $5.0 billion, a 291% increase. Year over year, Q3:19 spending was down 41% versus ...
(Date:10/17/2019)... (PRWEB) , ... October 17, 2019 , ... ... a patient receiving the right treatment before it progresses further. With many patients ... resources that can help their correct identification of skin cancer be extremely valuable. ...
(Date:10/11/2019)... ... 11, 2019 , ... The 'W' Initiative, a flagship women ... Health Month. The plans are aimed at improving community awareness on health issues ... to health checks and encouraging healthy lifestyle habits. , Slated to run all ...
Breaking Medicine Technology:
Cached News: